What Is a Monopoly Pharma Franchise and How Does It Work?The pharmaceutical industry is one of the most rapidly expanding sectors globally, and with it, various business models have emerged, offering ...
Jazz Pharma's diversified drug portfolio drives revenue growth. Zanidatamab shows promise with potential FDA approval in late ...
Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...
Chiesi has taken the lead in making an upfront investment in a new platform of inhalers, called the carbon minimal inhalers, ...
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), ...
The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.
Thomas brings more than 20 years of commercial and operations experience in the biopharmaceutical industry to Tonix Tonix is ...
"We are grateful to the FDA for their collaboration and review of our complete response package, which included a comprehensive safety assessment of the azenosertib program,” said Kimberly Blackwell, ...
Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback